Navigation Links
Lumbar Matrix(TM) Scan From SpineMatrix(R) Revolutionizes the Diagnosis of Low Back Pain
Date:6/10/2009

Accurately Locates the Origin of Pain While Reducing Healthcare Costs

AKRON, Ohio, June 10 /PRNewswire/ -- A new technology that revolutionizes the way low back pain is diagnosed and treated, while also significantly reducing healthcare costs, has been introduced by SpineMatrix(R) Inc., an Akron, Ohio-based medical technology company that specializes in advanced spinal diagnostics.

SpineMatrix's new, non-invasive Lumbar Matrix(TM) Scan uses high-speed computer processing of thousands of bioelectric signals to observe neuromuscular activity of the low back. The advanced diagnostic technology allows physicians to accurately identify the source of low back pain, which helps determine proper treatment and can result in significant savings for patients and the healthcare industry.

Low back pain is the most common and costly disabling condition in the United States, affecting nearly 31 million Americans. Current diagnostic methods used most frequently to detect lower back pain - such as X-rays, magnetic resonance imaging (MRI) and computed tomography (CT) scans - take into account the anatomy of the back but not the physiology. These methods often fail to pinpoint the precise cause of pain for this reason. More than 85 percent of patients with low back pain are never given a specific diagnosis, leading to ineffective treatment and billions of dollars spent in unnecessary healthcare costs. Additionally, invasive procedures, including surgery, may follow misdiagnosed lower back pain, further elevating healthcare spending. Since 1997, U.S. spending on diagnosis and treatment of spinal disorders increased 65 percent, as indicated by the Journal of the American Medical Association.

"The Lumbar Matrix Scan was developed to help physicians more precisely diagnose the cause of low back pain and prescribe the best form of treatment to alleviate the pain," said Ben Shappley, president and CEO of SpineMatrix. "Not only are we improving patient care, but we're providing a tool with the real potential to save millions of dollars for consumers, employers and health plans."

The Lumbar Matrix Scan collects thousands of bioelectrical signals from the back and reconstructs them into easily interpreted images, which helps physicians to differentially diagnose lower back pain by identifying disc, facet and muscle pathology.

The FDA-approved procedure monitors and displays the bioelectric signals produced by the paraspinal neuromuscular system using an array of 63 sensors that are placed on the back. The sensors are connected to a computer, which is calibrated to read the neuromuscular activity covered by the electrode grid.

Typically, the scan is used to capture three lower back scans of the patient in varying stances:

  • Standing relaxed with arms at side (baseline)
  • Flexing at the hips to a 20-degree angle
  • Standing with arms outstretched in front holding a three-pound weight in each hand

The image of the bioelectric signals produced by the low back muscles indicates the precise origin of low back pain. The procedure is fast, taking less than 15 minutes, and costs much less than an MRI, CT scan or invasive procedures. Factor in the savings on unnecessary treatments to relieve the pain, and the positive impact on healthcare costs significantly increases.

In blinded clinical studies at the Cleveland Clinic, Texas Back Institute and The Ohio State University College of Medicine, the Lumbar Matrix Scan was shown to be a safe, non-invasive and effective diagnostic procedure.

"Patients are already benefiting from the Lumbar Matrix Scan's ability to more accurately identify the source of low back pain," said Shappley. "But many individuals continue to suffer from ineffective treatments stemming from improper diagnosis. The Lumbar Matrix Scan provides a solution to improve diagnosis for these individuals, ultimately enabling physicians to prescribe the most effective treatments."

About SpineMatrix

Founded in 2003, SpineMatrix Inc. is a medical technology company specializing in advanced spinal diagnostics. A member of Northeast Ohio's thriving biomedical community, Akron-based SpineMatrix developed the Lumbar Matrix(TM) Scan, the first and only diagnostic procedure to produce an all-inclusive physiological image of the lower back.

SpineMatrix is dedicated to helping physicians accurately diagnose and treat patients with low back pain. Additional information about SpineMatrix is available at www.spinematrix.com.


'/>"/>
SOURCE SpineMatrix Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. RSB Spine, LLC Announces First Implantation of the InterPlate(TM) L for the Lumbar Spine
2. Siemens New S Class Revolutionizes the Paradigm of Ultrasound Workflow Today and Tomorrow
3. A New Era in the Application of Lab-on-a-Chip to Rapid Point-of-Care Diagnosis
4. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Germany & Austria
5. Transforming medical diagnosis with new scanning technology
6. Further 100 Million Euros Allocated to Netherlands-Based R&D Targeting the Early Diagnosis and Treatment of Disease
7. International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia"
8. In 2008, Ipsogen Reinforced its Leadership in Molecular Diagnosis and Monitoring of Leukemia
9. deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke
10. SpectraScience Awarded Patent for Its Optical Biopsy System and Methods for Tissue Diagnosis
11. University of Southern California Receives Cancer Diagnosis System for Detecting Esophageal Dysplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Feb. 16, 2017 UCHealth ( Aurora, ... LungDirect for pulmonary nodule patient management. In addition to ... a spot on the lung, UCHealth looks to improve ... data entry. Stephanie Brown, RN , ... nodule patients with an Excel spreadsheet, which was extremely ...
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
(Date:2/16/2017)... Feb. 16, 2017  Windtree Therapeutics, Inc. (Nasdaq: ... on developing aerosolized KL4 surfactant therapies for respiratory ... influenza study showed that aerosolized KL4 surfactant reduced ... well-established preclinical animal model. The Company believes that ... of evidence that supports the role of KL4 ...
(Date:2/16/2017)... PHOENIX and NEW YORK ... announced the near completion of their $7M Series B ... on top of the $3.5M led by Mesa Verde ... of 2016.  These resources will be directed towards further ... Test, PCDx, a comprehensive genomic profiling test and expanding ...
Breaking Biology Technology:
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... billion by 2021 from $8.3 billion in 2016 at ... 2016 to 2021. Report Includes - An overview ... global market trends, with data from 2015 and 2016, ... 2021. - Segmentation of the market on the basis ...
Breaking Biology News(10 mins):